Home Health professionals Conference 2009 Posters

Posters

Details of posters presented at the 2009 conference are below, where permission has been given they are available to download as a pdf by clicking on the title

Meningitis Research Foundation would like to thank Wyeth Vaccines for kindly donating the prize for best poster. The joint winners of this year's poster prize were

Ana Cehovin - Minor pili as novel vaccine candidates against Neisseria meningitidis
Bruno Pichon - Serotype replacement following the introduction of the PCV7 in the UK - Impact on the characteristics of pneumococci causing meningitis

Back to conference home

Author	Poster Title	Institution	Pathogen	Topic
Baharak Afshar	Overview of Group B Streptococcal screening and laboratory diagnostics in Europe	Respiratory and Systemic Infections Department, HPA, London	Group B Streptococcal	Diagnosis
Lorraine Als	Neuropsychological function in children following acute severe paediatric illness.	Academic Unit of Child & Adolescent Psychiatry, Imperial College London	Meningitis & septicaemia	Outcome
Lorraine Als	Salivary cortisol and alpha-amylase levels following admission to Paediatric Int ensive Care	Academic Unit of Child and Adolescent Psychiatry, Imperial College London, London, UK	Meningitis & septicaemia	Outcome, pathophysiology and treatment
Xilian Bai	Immunogenicity of an investigational recombinant meningococcal vaccine with and without outer membrane vesicles, against a group B strain representative of the Normandy outbreak.	Vaccine Evaluation Unit, Health Protection Agency, Manchester	Meningococcal	Vaccine
Xilian Bai	Comparison of complement sources in the meningococcal serogroup B serum bactericidal antibody assay	Vaccine Evaluation Unit, Health Protection Agency, Manchester	Meningococcal	Vaccine
Chris Bailey	A novel vaccine approach for Neisseria meningitidis; heat shock protein-antigen complexes (HspC) demonstrate cross-serogroup immunogenicity	ImmunoBiology Ltd., Babraham Research Campus, Babraham, Cambridge	Meningococcal	Vaccine
Chris Bayliss	Phase Variation of NadA, PorA and Other Surface Proteins During Meningococcal Carriage	Department of Genetics, University of Leicester, Leicester, UK	Meningococcal	Vaccine
Chris Bayliss	Influence of the Combination and Phase Variation Status of the Haemoglobin Receptors on Meningococcal Virulence	Department of Genetics, University of Leicester, Leicester, UK	Meningococcal	Pathogenesis
Rachel Bigwood	Exploring the expression levels of recombinant antigens and the murine response to Novartis recombinant MenB investigational vaccine	NIBSC, National Institute for Biological Standards and Control, Health Protection Agency, Potters Bar, Herts	Meningococcal	Vaccine
Barbara Bolgiano	Pre-clinical testing of the Meningitis Vaccine Project’s monovalent MenA-TT conjugate vaccine	Division of Bacteriology, National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, Potters Bar	Meningococcal	Vaccine
Charlotte Brookes	Correlation of high-throughput flow cytometry assays with live killing assays in the assessment of meningococcal vaccines.	Health Protection Agency, Centre of Emergency Preparedness and Response, Porton Down, Salisbury, UK	Meningococcal	Vaccine
Suzana Bukovski	Follow up of Invasive Bacterial Diseases at University Hospital for Infectious Diseases “Dr Fran Mihaljević” Zagreb, Croatia – January to July 2009	University Hospital for Infectious Diseases, Department of Clinical Microbiology, Zagreb	Meningitis & septicaemia	Outcome
Karena Burkin	Immunogenicity and thermal stability of a combined vaccine against Haemophilus influenzae type b and Neisseria meningitidis group C	Division of Bacteriology, National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, Potters Bar	Meningococcal	Vaccine
Katherine Cartwright	Factors contributing to the high mortality of adults with bacterial meningitis in Malawi	Dept of Microbiology, Leicester Royal Infirmary, Leicester, UK	Bacterial meningitis	Treatment / Outcome
Ana Cehovin	Minor pili as novel vaccine candidates against Neisseria meningitidis	The Centre for Molecular Microbiology and Infection, Flowers Building, Imperial College London	Meningococcal	Vaccine
Laura Clark	Findings from the 2003 Meningitis Research Foundation member survey	Meningitis Research Foundation / University of Bristol	Meningitis & septicaemia	Outcome
Ida Czumbel	The epidemiology of invasive meningococcal disease in Europe, 2007	European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden	Meningococcal	Vaccine
Jesper Damsgaard	Viral meningitis – a study of post-infectious cognitive dysfunction and associated neuropathology	Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark	Viral meningitis	Outcome
Peter Dull	Evaluation of polysaccharide and investigational meningococcal conjugate quadrivalent (ACWY) vaccines in adolescents by serum bactericidal assay using rabbit (rSBA) or human complement (hSBA)	Clinical Research, Novartis Vaccines and Diagnostics, Cambridge MA, USA	Meningococcal	Vaccine
Rachel M. Exley	A Conserved major pilin subunit in Neisseria meningitidis	Centre for Molecular Microbiology and Infection, Department of Infectious Disease, Flowers Building, Imperial College London	Meningococcal	Vaccine
Helen Findlow	Meningococcal group C and W135 immunological hyporesponsiveness in African toddlers	HPA, Manchester	Meningococcal	Vaccine
Helen Findlow	Competitive inhibition flow analysis assay for the non-culture detection of pneumococcal serotype capsular polysaccharide.	HPA, Manchester	Pneumococcal	Diagnosis
Helen Freeman	Staphylococcus aureus sepsis on PICU.	Bristol Royal Hospital for Children	Staphylococcal	Pathophysiology
Fang Gao	Pneumococcal conjugate vaccine stability from a physico-chemical point-of-view	Division of Bacteriology, National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, Potters Bar	Pneumococcal	Vaccine
Elizabeth Gonzalez	Proteoliposome and cochleate derived from serogroups B N. meningitides for mucosal vaccines	Immunology Department, Research Vice-presidency, Finlay Institute, P.O. Box 16017, Havana, Cuba	Meningococcal	Vaccine
Elizabeth Gonzalez	Production of large scale AFCo1 as Vaccine Adjuvant	Immunology Department, Research Vice-Presidency, Finaly Institute, Havana City, Cuba	Meningococcal	Vaccine
Elizabeth Gonzalez	Mucosal and systemic immune response induced by intranasal immunisation of C polysaccharide of Neisseria meningitidis C and AFCo1	Immunology Department, Research Vice-Presidency, Finaly Institute, Havana City, Cuba	Meningococcal	Vaccine
Elizabeth Gonzalez	Mucosal and Systemic Immune Response against Neisseria Meningitidis B Induced by Single Time Vaccination Strategy	Immunology Department, Finlay Institute, P.O. Box 16017, Havana, Cuba	Meningococcal	Vaccine
Steve Gray	The epidemiology and surveillance of meningococcal disease in England and Wales.	HPA Meningococcalcoccal Reference Unit, Manchester	Meningococcal	Epidemiology
Tanya A Haj-Hassan	Improving the early recognition of meningococcal disease in children and adolescents	Department of Primary Health Care, University of Oxford	Meningococcal	Recognition
Jason Hinds	Molecular serotyping of Streptococcus pneumoniae: a microarray-based tool with enhanced utility.	St. George’s, University of London	Pneumococcal	Epidemiology
Lee Hudson	A Survey of First-line antibiotic agent for Meningococcal Disease in Infants and Children in the England and Wales	Department of General Paediatrics and Adolescent Medicine. University College Hospital London	Meningococcal	Treatment
Syed Islam	fHBP variation and expression is independent of age, gender and disease outcome for meningococcal serogroup B disease	Global Safety Surveillance & Epidemiology, Wyeth Research, Collegeville, PA, USA	Meningococcal	Epidemiology
Amel Kechrid	Epidemiology of bacterial meningitis in Tunisian children (2000-2008)	Laboratoire de Microbiologie, Hôpital d’Enfants de Tunis, Tunisie	Bacterial meningitis	Epidemiology
Paul B. Keiser	Phase 1 study of an intramuscular meningococcal NOMV vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two porA’s and stablized Opc expression (HOPS-G).	Meningococcalcoccal Vaccine Program Division of Bacterial and Rickettsial Diseases Walter Reed Army Institute of Research	Meningococcal	Vaccine
Matthew Kelly	Prevalence of HSV, EBV and CMV in the cerebrospinal fluid of adults with clinically suspected bacterial meningitis in Malawi	Dept of Medicine, College of Medicine, University of Malawi, Blantyre, Malawi	Bacterial meningitis	Pathophysiology and treatment
Ravi Kirubanandan	Distal tibial growth arrest following meningococcal septicaemia; management and outcome of a series of 7 ankles.	Department of Paediatric Orthopaedics, Bristol Royal Hospital for Sick Children, Bristol	Meningococcal	Outcome
Ravi Kirubanandan	Sparing of the distal fibular physis in patients with physeal arrest around the ankle following Meningococcal septicaemia - a previously unreported phenomenon.	Department of Paediatric Orthopaedics, Bristol Royal Hospital for Sick Children, Bristol	Meningococcal	Outcome
Lorna E Lancaster	Structural and Immunological Characterisation of a Group B Streptococcus Conjugate Vaccine	Division of Bacteriology, NIBSC, HPA	Group B Streptococcal	Vaccine
Jay Laver	Nitric oxide metabolism of Neisseria meningitidis prevents host cell S-nitrosothiol formation: a novel mechanism of meningococcal pathogenesis.	Department of Infection and Immunity, The University of Sheffield	Meningococcal	Pathophysiology
Yanwen Li	Extensive injuries of human brain by Neisseria meningitidis infection	Department of Infectious Diseases, Imperial College London	Meningococcal	Pathophysiology
Angela Martino	Evaluation of three candidate vaccine antigens to Neisseria meningitidis in context of a recombinant protein-OMVNZ combination	NIBSC - HPA, Potters Bar, Herts	Meningococcal	Vaccine
Anne McNaughton	NarE, a novel ADPRT from Neisseria meningitidis can modulate innate and antigen specific immune responses.	School of Biochemistry and Immunology, Trinity College Dublin, Ireland	Meningococcal	Vaccine
Elaine McAleese	Is there a link?	West Yorkshire Health Protection Unit	Meningococcal	Epidemiology
Prasadarao Nemani	IL-10 administration during high-level bacteremia prevents brain damage in Escherichia coli K1 induced neonatal meningitis by increasing the pathogen clearance	Division of Infectious Diseases, Childrens Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA	E. Coli	Pathophysiology and treatment
Philipp Oster	First use of an investigational meningococcal serogroup B vaccine administered in combination with New Zealand (NZ) strain (NZ98/254) outer membrane vesicles (OMV) in healthy adults	Global Medical Affairs, Novartis Vaccines, Siena, Italy	Meningococcal	Vaccine
Philipp Oster	First use in adolescents of an investigational recombinant meningococcal B vaccine developed by reverse vaccinology	Global Medical Affairs, Novartis Vaccines, Siena, Italy	Meningococcal	Vaccine
Rishi Patel	Can we improve compliance with the algorithm for the management of children with a petechial rash and fever? – A completed Audit Cycle	Leighton District General Hospital, Mid Cheshire Hospitals NHS Foundation Trust, Crewe, UK	Meningococcal	Recognition
Tuula Pelkonen	Accuracy of Three Prognostic Scales in Childhood Bacterial Meningitis	Helsinki University Central Hospital, Hospital for Children and Adolescents, Helsinki, Finland	Bacterial meningitis	Recognition, pathophysiology and treatment
Bruno Pichon	Serotype replacement following the introduction of the PCV7 in the UK - Impact on the characteristics of pneumococci causing meningitis	Respiratory and Systemic Infection Laboratory, Health Protection Agency – Centre for infections, London, UK	Pneumococcal	Vaccine
Kate Pryde	Stroke In Paediatric Pneumococcal Meningitis	Southampton University Hospitals NHS Trust, Southampton	Pneumococcal	Pathophysiology
Susanna Ricci	The meningococcal ABC-type L-glutamate transporter GltT is necessary for the development of experimental meningitis in mice	LA.M.M.B., Dept. Molecular Biology, University of Siena, Italy	Meningococcal	Pathogenesis
Gerwin D. Rodenburg	Antibody responses after a reduced dose schedule with the pneumococcal conjugate vaccine; Timing of the booster dose in the first or second year of life	Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children’s Hospital, UMC Utrecht, The Netherlands	Pneumococcal	Vaccine
Gerwin D. Rodenburg	Lipid A variants in meningococcal disease and carriage isolates; prevalance and clinical impact	Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children’s Hospital, UMC Utrecht, The Netherlands	Meningococcal	Epidemiology
Lisa Sacks	Very early Fasciotomies prevents major limb loss in Children with Meningococcal Septicaemia.	Bristol Children's Hospital, Bristol	Meningococcal	Outcome
Katrine Schou	Bacterial and viral meningitis - Clinical manifestations, course and sequelae	Infectious Disease Research Unit, Department of Infectious Diseases Q, Aarhus University Hospital, Skejby, Brendstrupgaardsvej 100, 8200 Aarhus N, Denmark	Bacterial & viral meningitis	Recognition, treatmemt, outcome
Elske van Gils	Increase of nasopharyngeal carriage with serotype 19A after pneumococcal conjugate vaccine	University Medical Center Utrecht Department of Pediatric Immunology and Infectious diseases	Pneumococcal	Vaccine
Elske van Gils	Effect of reduced dose schedules with PCV-7 on pneumococcal carriage in children and adult contacts: a randomised controlled trial.	University Medical Center Utrecht Department of Pediatric Immunology and Infectious diseases	Pneumococcal	Vaccine
Victoria Wright	A genome-wide association study of meningococcal disease identifies novel susceptibility genes in a paediatric meningococcal patient cohort.	Paediatrics, Imperial College London, UK	Meningococcal	Pathophysiology